𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase-I dose escalation and sequencing study of docetaxel and continuous infusion topotecan in patients with advanced malignancies

✍ Scribed by James A. Posey; Hui Wang; JoElle Hamilton; Alma Delgrosso; Ruiwen Zhang; Timothy Freda; William C. Zamboni


Publisher
Springer
Year
2005
Tongue
English
Weight
251 KB
Volume
56
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Phase I dose and sequencing study of peg
✍ Paula M. Fracasso; Luis C. Rodriguez; Thomas J. Herzog; Carole L. Fears; Sherry πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 89 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Pegylated liposomal doxorubicin (PEG‐LD) and docetaxel have single‐agent activity in several malignancies. The authors conducted a Phase I trial to evaluate the maximum tolerated dose (MTD), toxicities, and effect of dose sequencing of this combination in patients with ad